In the present study, we aimed investigate the effects of ERS on autophagy, apoptosis and chemoresistance of human SCLC cells via the PI3K/AKT/mTOR signaling pathway, in order to provide a new therapeutic direction for SCLC patients. This evidence concerns the gene AKT1 and small cell lung carcinoma.